EventsMOL2NET'16, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 2nd ed.
Published
This submission belongs to the session 05. NICEXSM-02: North-Ibero-American Congress on Exp. and Simul. Methods, Valencia, Spain-Miami, USA, 2016 of the event MOL2NET'16, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 2nd ed.
Published date
24 Nov, 2016
Citation
Mirna Faz, José Simón Martínez, Israel Quijano-Hernández, Raúl Fajardo, Esvieta Tenorio-Borroto, Identification molecular and clinical characterization of CPV-2c in dogs from the state of Mexico., in Proceedings of MOL2NET'16, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 2nd ed., 15 October–20 October 2022, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-02-02004
Share
Email
Facebook
Twitter
LinkedIn

Identification molecular and clinical characterization of CPV-2c in dogs from the state of Mexico.

Israel Quijano-Hernández 2
Raúl Fajardo 1
1. Centro de Investigación y Estudios Avanzados en Salud Animal, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma del Estado de México. Carretera de Cuota Toluca-Atlacomulco kilómetro 15.5, C.P. 50200, Toluca, Estado de México.
2. Hospital Veterinario de Pequeñas Especies, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma del Estado de México Jesús Carranza N° 203, Col Universidad, Toluca Estado de México.
Abstract

Canine parvovirus type 2 (CPV-2) is the main etiological agent of viral enteritis in dogs. Actually in literature, CPV-2 has been reported with clinical signs that vary from the classical disease. In this study, we evaluated the clinical signs presented in 50 dogs infected naturally with CPV-2. All the infected dogs were analyzed by PCR and sequenced. Our data indicate that the CPV-2c is the most frequently genovariant in Mexico the 50 dogs belong to the CPV-2c, through the amino acid change 426 Asn-Glu and concerning clinical signs, the presence of either vomiting or enlarged lymph node was observed in all virally infected patients.

Keywords
Canine Parvovirus
Clinical signs
PCR
Poster
MOL2NET211116.docx.pdf
Designing, cloning and amplification of pDream2.1/MCS/CII-6 recombinant plasmid which includes a mexican scorpion Centruroides limpidus limpidus CII-6 gene
Design and Evaluation of cruzipain gene using Saccharomyces cerevisiae as a vaccine vector against Trypanosoma cruzi experimental infection